Direct-acting antivirals (DAAs) are a class of medications that target specific steps in the viral replication process, offering a highly effective treatment for viral infections such as hepatitis C. These drugs have revolutionized the management of such infections by significantly increasing cure rates and reducing treatment duration with fewer side effects compared to previous therapies.